HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The in vitro pharmacological profile of TD-1211, a neutral opioid receptor antagonist.

Abstract
The clinical efficacy of opioid receptor antagonists for the treatment of opioid-induced constipation (OIC) is established. Peripherally selective antagonists are intended to provide OIC symptom relief without compromising the analgesic effects of centrally penetrant opioid agonists. We describe the in vitro profile of a novel opioid receptor antagonist, TD-1211, at recombinant (human μ and δ, and guinea pig κ) and rodent native opioid receptors. TD-1211 bound with high affinity to human recombinant μ and δ, and guinea pig κ receptors expressed in CHO-K1 cells (pK d = 9.7, 8.6, and 9.9, respectively). The in vitro receptor selectivity of TD-1211 (μ ≈ κ > δ) is similar to that for the peripherally-selective opioid receptor antagonist methylnaltrexone, but contrasts with the μ selectivity of alvimopan. Functionally, TD-1211 behaved as an antagonist at all three receptor types in both recombinant expression systems (pK b = 9.6, 8.8 and 9.5, at μ, δ, and κ, respectively) and rodent native tissue preparations (μ and κ pA2s = 10.1 and 8.8, respectively (guinea pig ileum), and δ pK b = 8.4 (hamster vas deferens)). TD-1211 displayed a high degree of selectivity for opioid receptors over a broad panel of cellular targets. These in vitro data justified investigation of the preclinical in vivo activity of TD-1211 (Armstrong et al., Naunyn-Schmiedeberg's Arch Pharm, 2013).
AuthorsPamela R Tsuruda, Ross G Vickery, Daniel D Long, Scott R Armstrong, David T Beattie
JournalNaunyn-Schmiedeberg's archives of pharmacology (Naunyn Schmiedebergs Arch Pharmacol) Vol. 386 Issue 6 Pg. 479-91 (Jun 2013) ISSN: 1432-1912 [Electronic] Germany
PMID23549670 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • 3-(8-(2-(cyclohexylmethyl(2,3-dihydroxypropionyl)amino)ethyl)-8-azabicyclo(3.2.1)oct-3-yl)benzamide
  • Benzamides
  • Narcotic Antagonists
  • Piperidines
  • Quaternary Ammonium Compounds
  • Receptors, Opioid, delta
  • Receptors, Opioid, kappa
  • Receptors, Opioid, mu
  • Tropanes
  • methylnaltrexone
  • Naltrexone
  • alvimopan
Topics
  • Animals
  • Benzamides (pharmacology)
  • CHO Cells
  • Cricetinae
  • Cricetulus
  • Guinea Pigs
  • Humans
  • In Vitro Techniques
  • Male
  • Mesocricetus
  • Naltrexone (analogs & derivatives, pharmacology)
  • Narcotic Antagonists (pharmacology)
  • Piperidines (pharmacology)
  • Quaternary Ammonium Compounds (pharmacology)
  • Receptors, Opioid, delta (antagonists & inhibitors, metabolism)
  • Receptors, Opioid, kappa (antagonists & inhibitors, metabolism)
  • Receptors, Opioid, mu (antagonists & inhibitors, metabolism)
  • Tropanes (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: